Pete Stavropoulos's Stock Ratings

Cantor Fitzgerald Analyst

Pete Stavropoulos is an analyst at Cantor Fitzgerald. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/01/2025

Overall Average Return

-29.8%

Smart Score

28.2%

Overall Average Return Percentile

10th

Number of Ratings

49
Buy NowGet Alert
03/12/2025VYGRBuy Now
Voyager Therapeutics
$3.55
Pete Stavropoulos28%
ReiteratesOverweight → OverweightGet Alert
03/07/2025ARCTBuy Now
Arcturus Therapeutics
$12.50
Pete Stavropoulos28%
ReiteratesOverweight → OverweightGet Alert
03/04/2025PLRXBuy Now
Pliant Therapeutics
$1.64
Pete Stavropoulos28%
Reinstates → NeutralGet Alert
01/10/2025VYGRBuy Now
Voyager Therapeutics
$3.5561.41%
Pete Stavropoulos28%
→ $5.73Initiates → OverweightGet Alert
12/16/2024ARCTBuy Now
Arcturus Therapeutics
$12.50
Pete Stavropoulos28%
ReiteratesOverweight → OverweightGet Alert
12/09/2024KALVBuy Now
KalVista Pharma
$13.60
Pete Stavropoulos28%
ReiteratesOverweight → OverweightGet Alert
11/26/2024ALECBuy Now
Alector
$1.22
Pete Stavropoulos28%
Reiterates → OverweightGet Alert
11/15/2024ANNXBuy Now
Annexon
$1.85
Pete Stavropoulos28%
Reiterates → OverweightGet Alert
10/18/2024VSTMBuy Now
Verastem
$7.30
Pete Stavropoulos28%
Reiterates → OverweightGet Alert
10/03/2024VERABuy Now
Vera Therapeutics
$23.75350.53%
Pete Stavropoulos28%
$107 → $107ReiteratesOverweight → OverweightGet Alert
10/01/2024VERABuy Now
Vera Therapeutics
$23.75350.53%
Pete Stavropoulos28%
$107 → $107ReiteratesOverweight → OverweightGet Alert
09/23/2024VERABuy Now
Vera Therapeutics
$23.75350.53%
Pete Stavropoulos28%
$107 → $107ReiteratesOverweight → OverweightGet Alert
09/16/2024VERABuy Now
Vera Therapeutics
$23.75350.53%
Pete Stavropoulos28%
$107 → $107ReiteratesOverweight → OverweightGet Alert
09/09/2024VERABuy Now
Vera Therapeutics
$23.75350.53%
Pete Stavropoulos28%
$107 → $107ReiteratesOverweight → OverweightGet Alert
09/06/2024VERABuy Now
Vera Therapeutics
$23.75350.53%
Pete Stavropoulos28%
$107 → $107ReiteratesOverweight → OverweightGet Alert
08/08/2024PLRXBuy Now
Pliant Therapeutics
$1.64
Pete Stavropoulos28%
Reiterates → OverweightGet Alert
08/06/2024ARCTBuy Now
Arcturus Therapeutics
$12.50
Pete Stavropoulos28%
Reiterates → OverweightGet Alert
07/29/2024ALECBuy Now
Alector
$1.22
Pete Stavropoulos28%
Reiterates → OverweightGet Alert
06/27/2024DNTHBuy Now
Dianthus Therapeutics
$21.70
Pete Stavropoulos28%
Initiates → OverweightGet Alert
06/20/2024ALECBuy Now
Alector
$1.22
Pete Stavropoulos28%
Reiterates → OverweightGet Alert
06/18/2024JSPRBuy Now
Jasper Therapeutics
$5.38
Pete Stavropoulos28%
Reiterates → OverweightGet Alert
06/05/2024ANNXBuy Now
Annexon
$1.85
Pete Stavropoulos28%
Reiterates → OverweightGet Alert
05/09/2024ALECBuy Now
Alector
$1.22
Pete Stavropoulos28%
Reiterates → OverweightGet Alert
04/24/2024ANNXBuy Now
Annexon
$1.85
Pete Stavropoulos28%
Reiterates → OverweightGet Alert
04/03/2024ANNXBuy Now
Annexon
$1.85
Pete Stavropoulos28%
Reiterates → OverweightGet Alert
01/08/2024VERABuy Now
Vera Therapeutics
$23.75
Pete Stavropoulos28%
Initiates → OverweightGet Alert
10/12/2023JSPRBuy Now
Jasper Therapeutics
$5.3811.52%
Pete Stavropoulos28%
→ $60ReiteratesOverweight → OverweightGet Alert
09/22/2023ALECBuy Now
Alector
$1.22965.57%
Pete Stavropoulos28%
→ $13Initiates → OverweightGet Alert
09/19/2023RZLTBuy Now
Rezolute
$4.0025%
Pete Stavropoulos28%
→ $5ReiteratesOverweight → OverweightGet Alert
08/22/2023PLRXBuy Now
Pliant Therapeutics
$1.643741.46%
Pete Stavropoulos28%
→ $63ReiteratesOverweight → OverweightGet Alert
08/22/2023ARCTBuy Now
Arcturus Therapeutics
$12.50332%
Pete Stavropoulos28%
→ $54ReiteratesOverweight → OverweightGet Alert
08/22/2023ANNXBuy Now
Annexon
$1.85602.7%
Pete Stavropoulos28%
→ $13ReiteratesOverweight → OverweightGet Alert
08/08/2023ANNXBuy Now
Annexon
$1.85602.7%
Pete Stavropoulos28%
$18 → $13MaintainsOverweightGet Alert
08/01/2023ANNXBuy Now
Annexon
$1.85872.97%
Pete Stavropoulos28%
→ $18ReiteratesOverweight → OverweightGet Alert
07/17/2023ABOSBuy Now
Acumen Pharmaceuticals
$1.051137.98%
Pete Stavropoulos28%
→ $13ReiteratesOverweight → OverweightGet Alert
07/14/2023ARCTBuy Now
Arcturus Therapeutics
$12.50332%
Pete Stavropoulos28%
→ $54ReiteratesOverweight → OverweightGet Alert
06/28/2023RZLTBuy Now
Rezolute
$4.0025%
Pete Stavropoulos28%
$7 → $5MaintainsOverweightGet Alert
06/27/2023ORTXBuy Now
Orchard Therapeutics
Pete Stavropoulos28%
→ $15ReiteratesOverweight → OverweightGet Alert
05/18/2023ABOSBuy Now
Acumen Pharmaceuticals
$1.051137.98%
Pete Stavropoulos28%
→ $13Initiates → OverweightGet Alert
05/01/2023PLRXBuy Now
Pliant Therapeutics
$1.643741.46%
Pete Stavropoulos28%
$52 → $63MaintainsOverweightGet Alert
03/28/2023ORTXBuy Now
Orchard Therapeutics
Pete Stavropoulos28%
$3 → $15MaintainsOverweightGet Alert
03/20/2023IMNMBuy Now
Immunome
$8.86-9.71%
Pete Stavropoulos28%
→ $8Reiterates → OverweightGet Alert
03/14/2023ANNXBuy Now
Annexon
$1.85872.97%
Pete Stavropoulos28%
$22 → $18MaintainsOverweightGet Alert
03/09/2023JSPRBuy Now
Jasper Therapeutics
$5.3811.52%
Pete Stavropoulos28%
→ $60Reiterates → OverweightGet Alert
02/07/2023JSPRBuy Now
Jasper Therapeutics
$5.3811.52%
Pete Stavropoulos28%
$100 → $60Reiterates → OverweightGet Alert
01/23/2023PLRXBuy Now
Pliant Therapeutics
$1.643070.73%
Pete Stavropoulos28%
$40 → $52MaintainsOverweightGet Alert
11/02/2022ARCTBuy Now
Arcturus Therapeutics
$12.50252%
Pete Stavropoulos28%
$39 → $44MaintainsOverweightGet Alert
08/16/2022ANNXBuy Now
Annexon
$1.851089.19%
Pete Stavropoulos28%
$27 → $22MaintainsOverweightGet Alert
06/15/2022RZLTBuy Now
Rezolute
$4.00125%
Pete Stavropoulos28%
→ $9Initiates → OverweightGet Alert